🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The study was designed to obtain data about the efficacy and safety of 3 do...
Status
Completed
Location
Novartis Investigative site
Start Date
2006-12
Trial ID
NCT00403845
Treatments Being Tested
The study is designed to obtain safety and efficacy data on three dose leve...
Status
Completed
Location
Colorado Allergy and Asthma Centres, P.C.
Start Date
2006-11
Trial ID
NCT00403637
Treatments Being Tested
This study was designed to assess the safety of indacaterol (300 µg and 600...
Status
Completed
Location
Novartis Investigator Site
Start Date
2007-09
Trial ID
NCT00529529
Treatments Being Tested
This study was designed to provide data about the safety and efficacy of 3 ...
Status
Completed
Location
Novartis Investigative Site
Start Date
2006-11
Trial ID
NCT00403754
Treatments Being Tested
The study is designed to obtain safety and efficacy data on three dose leve...
Status
Completed
Location
Novartis
Start Date
2006-10
Trial ID
NCT00396604
Treatments Being Tested
This study compares the cardiac safety of inhaled indacaterol with that of ...
Status
Completed
Location
Novartis investigative site
Start Date
2008-04
Trial ID
NCT01263808
Treatments Being Tested
This study was designed to assess the efficacy and long-term safety of 300 ...
Status
Completed
Location
Novartis Investigator Site
Start Date
2006-10
Trial ID
NCT00393458
Treatments Being Tested
This is a phase I, randomised, placebo-controlled 2-part study to assess th...
Status
Completed
Location
Research Site
Start Date
2015-10
Trial ID
NCT02573155
Treatments Being Tested
Stage 1 of the study is designed to provide data about the risk-benefit of ...
Status
Completed
Location
Pinnacle Research Group, LLC
Start Date
2007-04
Trial ID
NCT00463567
This study is designed to evaluate the safety and pharmacokinetic effects o...
Status
Completed
Location
Novartis Investigative Site
Start Date
2006-11
Trial ID
NCT00416702
Treatments Being Tested